1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with indium tris(tropolonate) in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (indium tris(tropolonate)) | Trials (indium tris(tropolonate)) | Recent Studies (post-2010) (indium tris(tropolonate)) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 64 | 2 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clague, J; Dixon, CM; Henderson, BL; Ind, PW; Lavender, JP; Peters, AM; Stuttle, AW; Tam, FW | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and indium tris(tropolonate)
Article | Year |
---|---|
Inhaled platelet-activating factor causes pulmonary neutrophil sequestration in normal humans.
Topics: Administration, Inhalation; Adult; Blood Platelets; Bronchial Provocation Tests; Erythrocytes; Humans; Indium Radioisotopes; Lung; Male; Neutrophils; Organometallic Compounds; Platelet Activating Factor; Platelet Count; Radionuclide Imaging; Technetium; Time Factors; Tropolone | 1992 |